Ivacaftor
Systematic Name
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
Therapeutic Category
Cystic fibrosis
CAS No
873054-44-5
Suitable Formulations
Solid
Approvals
Under Development
Home » Ivacaftor
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
Cystic fibrosis
873054-44-5
Solid
Under Development
Sthree chemicals is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2012 by a team with vast experience across the pharmaceutical value chain, the company is on a mission to become the most preferred partner for pharmaceuticals.